Incorporated in 1994, Mono Pharmacare is engaged in the marketing and distribution of pharmaceutical products. Through its distribution segment, company deals with (distributors and stockists) 168 pharmaceutical companies and connected with 3,036 customers/vendors who are a mix of retail pharmacy stores and wholesalers.
Besides the distribution business, company sells its own pharma products under the brand “DLS Export”, which are manufactured by contract manufacturers on behalf of the company. Its product portfolio includes drugs like antibiotics, antifungal, anti cough cold & anti-allergic, antacid and antiemetics, skincare, antiseptic, cardiac, diabetic and cosmetics etc.
Their business segments are only in the western region of Gujarat, particularly in Ahmedabad city. Promoters have been the pillars of the company’s growth since the beginning.
Now, Mono Pharmacare Limited is coming out with its initial public offer (IPO). The IPO will be a fresh issue. The money raised through the fresh issue will be utilised to meet working capital requirements, to meet issue expenses & for general corporate purposes.
|Company Name||Mono Pharmacare Limited||Company Type||Private|
|IPO Type||SME||Mono Pharmacare Limited IPO Opening Date||28 August 2023|
|Mono Pharmacare Limited IPO Closing Date||30 August 2023||Mono Pharmacare Limited IPO Allotment Status||4 September 2023|
|Credit of Shares to the Demat Account||6 September 2023||Mono Pharmacare Limited IPO Listing Date||7 September 2023|
|Mono Pharmacare Limited IPO Face Value||₹ 10 per share||Mono Pharmacare Limited IPO Lot Size||4000 shares|
|Mono Pharmacare Limited IPO Issue Size||₹ 14.84 crore||Mono Pharmacare Limited IPO to be Listed on||NSE SME|
|Mono Pharmacare Limited IPO Price band||₹ 26-28 per share|